PATENT CLAIM ANALYSIS

Application Number: 16168753
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-02
Patent Classification: ["546", "268400"]

Abstract:
The present embodiments provide for substituted triazolylpyridine derivative compounds, and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are useful for modulating the activity of histone demethylase enzymes. Additionally, the subject compounds and compositions are useful for the treatment of cancer or other neoplastic diseases, or maladies associated with abnormal histone demethylase activity. Accordingly, the substituted triazolylpyridine derivative compounds described herein are useful in methods and medicaments for treating cancer.

Claim (Index 3):
The compound of  claim 1 , wherein R 4  and R 5  are hydrogen, and R 3  is optionally substituted aralkyl, aryloxyalkyl, cyclylalkyl, or heterocyclylalkyl.

Metadata:
- Claim Count in Document: 3.0
- Percentile: 97.0
- Lexical Diversity: 1.81818
- Patent Class: 546.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15487362', '15230966', '15616319', '15588495', '14855269']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8017108019600748
- 35 USC 102 Novelty (BERT): 0.5462764825846272
- Combined Prediction Score: 0.77616737002253
- Mean Citation Score: 368.728752
- Max Citation Score: 396.93008
- Similarity Product: 301.58324654531475

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test